MedTrace Logo

The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy

NCT05432232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-12-02

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to evaluate the technical success and safety profile of the HistoSonics Investigational System for the treatment of primary solid renal tumors.

Conditions

  • Renal Cancer
  • Tumor, Solid
  • Kidney Cancer
  • Tumor
  • Tumor, Benign
  • Kidney Neoplasms

Interventions

DEVICE

HistoSonics Investigational System

The HistoSonics Investigational System is intended for the non-invasive destruction of kidney tissue using histotripsy, a non-thermal mechanical process of focused ultrasound.

Sponsors & Collaborators

  • HistoSonics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2024-12-28
Completion
2025-06-06
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432232 on ClinicalTrials.gov